Comparing Long-Acting Antipsychotic Discontinuation Rates Under Ordinary Clinical Circumstances: A Survival Analysis from an Observational, Pragmatic Study-Reference-Cited by-同舟云学术

Comparing Long-Acting Antipsychotic Discontinuation Rates Under Ordinary Clinical Circumstances: A Survival Analysis from an Observational, Pragmatic Study

Published:2021-03-29 Issue:6 Volume:35 Page:655-665
ISSN:1172-7047
Container-title:CNS Drugs
language:en
Short-container-title:CNS Drugs

Author:

Bertolini Federico^ORCID,Ostuzzi Giovanni,Pievani Michela,Aguglia Andrea,Bartoli Francesco,Bortolaso Paola,Callegari Camilla,Caroleo Mariarita,Carrà Giuseppe,Corbo Mariangela,D’Agostino Armando,De Fazio Pasquale,Magliocco Fabio,Martinotti Giovanni,Ostinelli Edoardo Giuseppe,Piccinelli Marco Piero,Tedeschi Federico,Barbui Corrado,

Funder

Università degli Studi di Verona

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Psychiatry and Mental health,Clinical Neurology

Link

https://link.springer.com/content/pdf/10.1007/s40263-021-00809-w.pdf

Reference39 articles.

1. Bowtell M, Ratheesh A, McGorry P, Killackey E, O’Donoghue B. Clinical and demographic predictors of continuing remission or relapse following discontinuation of antipsychotic medication after a first episode of psychosis. A systematic review. Schizophr Res. 2018;197:9–18. https://doi.org/10.1016/j.schres.2017.11.010.

2. Taylor DM, Velaga S, Werneke U. Reducing the stigma of long acting injectable antipsychotics—current concepts and future developments. Nord J Psychiatry. 2018;72(sup1):S36–9. https://doi.org/10.1080/08039488.2018.1525638.

3. Barnes TR, Drake R, Paton C, Cooper SJ, Deakin B, Ferrier IN, et al. Evidence-based guidelines for the pharmacological treatment of schizophrenia: updated recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2020;34(1):3–78. https://doi.org/10.1177/0269881119889296.

4. Galletly C, Castle D, Dark F, Humberstone V, Jablensky A, Killackey E, et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders. Aust N Z J Psychiatry. 2016;50(5):410–72. https://doi.org/10.1177/0004867416641195.

5. NICE. Psychosis and schizophrenia in adults: prevention and management. Clinical guideline [CG178]. 2014. https://www.nice.org.uk/guidance/cg178. Accessed 1 Sept 2020.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Acting Injectable Antipsychotics in the Geriatric Population: A longitudinal Study;The American Journal of Geriatric Psychiatry;2024-07

2. Sociodemographic and clinical factors associated with prescription of first- versus second-generation long-acting antipsychotics in incarcerated adult males;International Clinical Psychopharmacology;2023-10-02

3. Treatment Retention Rates of 3-monthly Paliperidone Palmitate and Risk Factors Associated with Discontinuation: A Population-based Cohort Study;Clinical Psychopharmacology and Neuroscience;2023-08-31

4. Clinical trajectories of individuals with severe mental illness continuing and discontinuing long-acting antipsychotics: a one-year mirror-image analysis from the STAR Network Depot study;Schizophrenia;2023-04-17

5. High Rate of Discontinuation during Long-Acting Injectable Antipsychotic Treatment in Patients with Psychotic Disorders;Biomedicines;2023-01-22